Oncology - Exhibitor

Contact Information:
 

Erik Gustafson
Oncology/Hematology Specialist
Jakafi (ruxolitinib)
Pemazyre (pemigatinib)
(612) 875-2575
egustafson@incyte.com

Julie Knudsvig
Oncology/Hematology Specialist
Monjuvi (tafasitamab)
(612) 850-1551
jknudsvig@incyte.com

Lori Pechinski
Oncology/Hematology Specialist
Jakafi (ruxolitinib)
Pemazyre (pemigatinib)
Monjuvi (tafasitamab)
(715) 660-0526
lpechinski@incyte.com

 

 

 

 

 

 

 

Virtual Exhibit Hall Home

 

Click for Incyte Product Booth

Incyte is a global biopharmaceutical company that is focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of novel medicines.

Since 2002 Incyte has remained committed to the relentless pursuit of science that can improve the lives of patients, make a difference in healthcare and build sustainable value for our stakeholders.

Incyte’s unique expertise in medicinal chemistry and biology have enabled us to create a diversified pipeline of clinical candidates, the majority of which were discovered by Incyte scientists. We are advancing a growing portfolio of medicines across two franchises: Oncology and Inflammation & Autoimmunity.

Headquartered in Wilmington, Delaware, Incyte has operations in the U.S., Canada, Europe and Japan.

For more information, visit Incyte.com and follow @Incyte.

To contact US Medical Information, please call or email at 1-855-4MED-INFO (855-463-3463) or medinfo@incyte.com.